Actively Recruiting
Study of Intestinal Development and Diseases Including Necrotizing Enterocolitis in Neonates and Infants up to 2 Years Undergoing Intestinal Surgery or Biopsy
Led by Boston Children's Hospital · Updated on 2026-03-27
100
Participants Needed
1
Research Sites
173 weeks
Total Duration
AI-Summary
What This Trial Is About
Research on early intestinal development often uses mouse models, but these do not perfectly match human development since timing and key proteins differ. This study aims to better understand important parts of intestinal growth in human babies, focusing especially on conditions like necrotizing enterocolitis NEC that occur early in life. The goal is to gain insights that mouse studies cannot provide. The study involves observing neonates and infants up to 2 years old who are scheduled for intestinal surgery or procedures like esophogastroduodenoscopy or colonoscopy that include biopsies. Researchers will examine tissue samples and stool collected around the time of these clinical procedures to study cells in the intestine, immune system changes, and beneficial microbes in the gut. Participants will be monitored during their clinically required procedures, with data collected at or near the time of surgery or biopsy. The main outcomes include counting intestinal stem and mature cells, assessing immune system changes within 48 hours before or after surgery, and measuring beneficial microbes in stool samples taken around surgery. The study continues until December 2034, with no extra treatments involved, focusing on observation and sample analysis.
CONDITIONS
Brief Title
Study of Normal Intestinal Development and Disease in Premature and Term Neonates
Research Team
A
Amy O'Connell, MD, PhD
K
Kate Eident, BS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here